Flomics Biotech SL

Startup Competition
We are redefining the future of healthcare by uncovering the secrets hidden within our blood to catch complex diseases long before they manifest. Our mission is to transform cancer screening from a reactive procedure into a proactive, non-invasive standard of care. By harnessing the dynamic power of RNA and advanced artificial intelligence, we identify molecular signatures at the earliest stages, when treatment is most effective and lives are saved. Our solutions empower medical researchers, clinical practitioners, and pharmaceutical companies with the tools needed to navigate the complexities of genomic data. We provide a comprehensive ecosystem that ranges from innovative multi-cancer liquid biopsy tests to a sophisticated cloud-based platform for genomic analysis. Whether it’s supporting large-scale clinical trials or accelerating biomarker discovery, our technology simplifies the journey from a single blood sample to actionable health insights. What sets us apart is our focus on the entire transcriptomic landscape, offering a far more detailed snapshot of real-time organ health than traditional DNA tests. By combining user-friendly, high-performance software with rigorous scientific expertise, we make sophisticated precision medicine accessible and scalable. Choosing us means partnering with a team that balances cutting-edge innovation with a commitment to making early detection a universal reality.